Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Neoplasms and CBR1[original query] |
---|
Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity. Pharmacogenetics and genomics 2008 Jul 18 (7): 623-31. Fan L, Goh BC, Wong CI, Sukri N, Lim SE, Tan SH, Guo JY, Lim R, Yap HL, Khoo YM, Iau P, Lee HS, Lee SC |
CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients. Cancer science 2008 Oct 99 (10): 2045-54. Lal Suman, Sandanaraj Edwin, Wong Zee Wan, Ang Peter C S, Wong Nan Soon, Lee Edmund J D, Chowbay Balr |
Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Nov . Blanco JG, Sun CL, Landier W, Chen L, Esparza-Duran D, Leisenring W, Mays A, Friedman DL, Ginsberg JP, Hudson MM, Neglia JP, Oeffinger KC, Ritchey AK, Villaluna D, Relling MV, Bhatia S |
NNK reduction pathway gene polymorphisms and risk of lung cancer. Molecular carcinogenesis 2015 Jun 54 Suppl 1 E94-E102. Modesto Jennifer L, Hull Anna, Angstadt Andrea Y, Berg Arthur, Gallagher Carla J, Lazarus Philip, Muscat Joshua |
Distinct genotype-dependent differences in transcriptome responses in humans exposed to environmental carcinogens. Carcinogenesis 2015 Aug . Espín-Pérez Almudena, de Kok Theo M C M, Jennen Danyel G J, Hendrickx Diana M, De Coster Sam, Schoeters Greet, Baeyens Willy, van Larebeke Nicolas, Kleinjans Jos C |
Risk factors for anthracycline-associated cardiotoxicity. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2015 Nov . Reinbolt Raquel E, Patel Roshan, Pan Xueliang, Timmers Cynthia Dawn, Pilarski Robert, Shapiro Charles L, Lustberg Maryam |
Association between CBR1 polymorphisms and NSCLC in the Chinese population. Oncology letters 2017 Nov 14 (5): 6291-6297. Guo Yong, Shen Yingying, Xia Yongming, Gu Jianzho |
Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients. Journal of translational medicine 2017 Nov 15 (1): 235. Cao Hai-Xia, Miao Chao-Feng, Yan Liang, Tang Ping, Zhang Li-Rong, Sun Li |
Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia. Pharmacogenomics 2021 9 22 (14): 885-901. Petrykey Kateryna, Rezgui Aziz M, Guern Mathilde Le, Beaulieu Patrick, St-Onge Pascal, Drouin Simon, Bertout Laurence, Wang Fan, Baedke Jessica L, Yasui Yutaka, Hudson Melissa M, Raboisson Marie-Josée, Laverdière Caroline, Sinnett Daniel, Andelfinger Gregor U, Krajinovic Ma |
Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy. Life sciences 2021 3 276 119392. Cui Lulu, Huang Jia, Zhan Yongtao, Qiu Ni, Jin Huan, Li Jia, Huang Huiqi, Li Hongshe |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: